Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Feb. 29, 2016	Feb. 28, 2015	Feb. 29, 2016	Feb. 28, 2015	May. 31, 2015	May. 31, 2014
NET SALES	$ 88,893	$ 95,605	$ 281,854	$ 294,323
COST OF SALES (exclusive of amortization shown separately below)	34,130	33,971	106,660	106,571
GROSS PROFIT	54,763	61,634	175,194	187,752
OPERATING EXPENSES:
Research and development	6,910	7,280	20,500	21,474
Selling and marketing	13,251	13,513	42,057	43,942
Distribution	4,155	4,986	12,969	15,342
General and administrative	11,779	9,362	33,133	30,943
Amortization expense	13,575	13,615	40,745	40,948
Total operating expenses	49,670	48,756	149,404	152,649
INCOME FROM OPERATIONS	5,093	12,878	25,790	35,103
NON-OPERATING (EXPENSE) INCOME:
Interest income	48	42	132	131
Interest expense	(22,329)	(21,793)	(67,275)	(66,913)
Other, net	(317)	177	(366)	465
Total non-operating net expense	(22,598)	(21,574)	(67,509)	(66,317)
LOSS BEFORE INCOME TAXES	(17,505)	(8,696)	(41,719)	(31,214)
(BENEFIT) PROVISION FOR INCOME TAXES	(8,845)	30,744	(14,046)	22,783
NET LOSS	(8,660)	$ (39,440)	(27,673)	$ (53,997)	$ (60,725)	$ (182,257)
Net loss attributable to noncontrolling interest	(237)		(237)
NET LOSS ATTRIBUTABLE TO IMMUCOR, INC.	(8,423)	$ (39,440)	(27,436)	$ (53,997)
NET SALES	88,893	95,605	281,854	294,323
COST OF SALES (exclusive of amortization shown separately below)	34,130	33,971	106,660	106,571
GROSS PROFIT	$ 54,763	$ 61,634	$ 175,194	$ 187,752